Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Chung

Showing results (301-310 of 329) with videos related to

Pageof 33
Sort By:
Emerging Infectious Diseases|November 2, 2023
Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018-2022Faruque Ahmed, Mary Patricia Nowalk, Richard K Zimmerman, et al.
Influenza and Other Respiratory Viruses|February 16, 2022
Vaccine effectiveness against COVID-19 among symptomatic persons aged ≥12 years with reported contact with COVID-19 cases, February-September 2021Jessie R Chung, Sara S Kim, Edward A Belongia, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Influenza Antibody Levels Associated with Laboratory-Confirmed Influenza in a Test-Negative Study Design, US Flu VE Network, November 2018-May 2019Brendan Flannery, Jessie R Chung, Crystal Holiday, et al.
The Journal of Infectious Diseases|January 9, 2016
Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United StatesManjusha Gaglani, Jessica Pruszynski, Kempapura Murthy, et al.
Vaccine|June 16, 2022
Vaccine-associated attenuation of subjective severity among outpatients with influenzaJessie R Chung, Sara S Kim, Brendan Flannery, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2022
Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza SeasonAshley M Price, Brendan Flannery, H Keipp Talbot, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2020
Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020Mark W Tenforde, Rebecca J Garten Kondor, Jessie R Chung, et al.
The Journal of Infectious Diseases|January 24, 2018
Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United StatesBrendan Flannery, Catherine Smith, Rebecca J Garten, et al.
The Journal of Infectious Diseases|September 9, 2021
Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February-May 2021Sara S Kim, Jessie R Chung, Edward A Belongia, et al.
MMWR. Morbidity and Mortality Weekly Report|February 15, 2019
Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019Joshua D Doyle, Jessie R Chung, Sara S Kim, et al.
Pageof 33

Showing results (301-310 of 329) with videos related to

Sort By:
Pageof 33
Emerging Infectious Diseases|November 2, 2023
Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018-2022Faruque Ahmed, Mary Patricia Nowalk, Richard K Zimmerman, et al.
Influenza and Other Respiratory Viruses|February 16, 2022
Vaccine effectiveness against COVID-19 among symptomatic persons aged ≥12 years with reported contact with COVID-19 cases, February-September 2021Jessie R Chung, Sara S Kim, Edward A Belongia, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Influenza Antibody Levels Associated with Laboratory-Confirmed Influenza in a Test-Negative Study Design, US Flu VE Network, November 2018-May 2019Brendan Flannery, Jessie R Chung, Crystal Holiday, et al.
The Journal of Infectious Diseases|January 9, 2016
Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United StatesManjusha Gaglani, Jessica Pruszynski, Kempapura Murthy, et al.
Vaccine|June 16, 2022
Vaccine-associated attenuation of subjective severity among outpatients with influenzaJessie R Chung, Sara S Kim, Brendan Flannery, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2022
Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza SeasonAshley M Price, Brendan Flannery, H Keipp Talbot, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2020
Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020Mark W Tenforde, Rebecca J Garten Kondor, Jessie R Chung, et al.
The Journal of Infectious Diseases|January 24, 2018
Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United StatesBrendan Flannery, Catherine Smith, Rebecca J Garten, et al.
The Journal of Infectious Diseases|September 9, 2021
Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February-May 2021Sara S Kim, Jessie R Chung, Edward A Belongia, et al.
MMWR. Morbidity and Mortality Weekly Report|February 15, 2019
Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019Joshua D Doyle, Jessie R Chung, Sara S Kim, et al.
Pageof 33